share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K:員工持股年度報告
美股SEC公告 ·  06/26 04:26
牛牛AI助理已提取核心訊息
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The...Show More
Bristol-Myers Squibb Company (BMY.US), a leading pharmaceutical company, has filed its annual Form 11-K with the Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial performance of the Bristol-Myers Squibb Company Employee Incentive Thrift Plan, which is a defined contribution retirement plan for its employees. The plan includes a variety of investment options and is subject to ERISA provisions. The financial statements, audited by Withum Smith + Brown, PC, indicate that the plan's net assets available for benefits decreased from $62,527,000 at the beginning of the year to $60,622,000 at the end of the year. The decrease is attributed to distributions and withdrawals exceeding total additions from net investment income and contributions. The plan's investments are held in the Savings Plan Master Trust, which includes mutual funds, company stock, money market funds, and other assets. The report, signed by Senior Vice President and Treasurer Sandra Ramos-Alves on June 25, 2024, confirms the plan's compliance with U.S. GAAP and its tax-exempt status under the Code.
一家知名藥品公司Bristol-Myers Squibb Company (BMY.US)以其員工退休儲蓄計劃年度報告表格11-K向證券交易委員會報告了截至2023年12月31日的財年度。報告詳細描述了該退休儲蓄計劃的財務表現,該計劃是爲其員工設立的一項約定繳款式養老計劃,包括多種投資類型,並受ERISA法規的約束。由Withum Smith+Brown,PC審計的財務報表顯示,計劃上年度可用於福利的淨資產由年初的$62,527,000降至年末的$60,622,000。這一減少歸因於淨投資收益和繳費總額不及全部提現和撤回的情況。該計劃的投資由儲蓄計劃總託管中心持有,包括共同基金、公司股票、貨幣市場基金和其他資產。該報告由Senior Vice President和Treasurer Sandra Ramos-Alves於2024年6月25日簽署,確認了該計劃遵守美國通用會計準則並在稅法下獲得免稅地位。
一家知名藥品公司Bristol-Myers Squibb Company (BMY.US)以其員工退休儲蓄計劃年度報告表格11-K向證券交易委員會報告了截至2023年12月31日的財年度。報告詳細描述了該退休儲蓄計劃的財務表現,該計劃是爲其員工設立的一項約定繳款式養老計劃,包括多種投資類型,並受ERISA法規的約束。由Withum Smith+Brown,PC審計的財務報表顯示,計劃上年度可用於福利的淨資產由年初的$62,527,000降至年末的$60,622,000。這一減少歸因於淨投資收益和繳費總額不及全部提現和撤回的情況。該計劃的投資由儲蓄計劃總託管中心持有,包括共同基金、公司股票、貨幣市場基金和其他資產。該報告由Senior Vice President和Treasurer Sandra Ramos-Alves於2024年6月25日簽署,確認了該計劃遵守美國通用會計準則並在稅法下獲得免稅地位。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。